Haona Bao | Medicinal Chemistry | Best Researcher Award

Published on by Top Pharmaceutical

Haona Bao | Medicinal Chemistry | Best Researcher Award

Ms. Haona Bao, The Ohio State Univerisity, United States

Ms. Haona Bao is a dynamic Ph.D. candidate in Food Science and Technology at The Ohio State University 🎓. With academic roots at UC Davis and Tennessee State University, her research spans vibrational spectroscopy, food quality, and fibromyalgia diagnostics 🧪. She has published impactful studies on encapsulation, essential oils, and Raman-based detection in top journals 📚. As a teaching assistant, lab safety manager, and award-winning presenter 🏆, she excels in scientific communication and leadership. Haona combines analytical skills, regulatory expertise, and creativity to shape the future of food safety and health innovation 🌾🔬.

Publication Profile

Google Scholar

Education

Ms. Haona Bao is an accomplished scholar with a strong academic foundation in food science. She is currently pursuing her Ph.D. in Food Science and Technology at The Ohio State University (expected August 2025) 🧪. She earned her Master of Science in Food and Animal Science from Tennessee State University between 2019 and 2021 🐓🥼. Her academic journey began at the University of California, Davis, where she obtained her Bachelor of Science in Food Science and Technology in 2019 🍇🔬. Her diverse educational background reflects a deep commitment to advancing innovation in food systems and safety 🌱📘.

Experience

Ms. Haona Bao has extensive research experience in food science and technology. At The Ohio State University (2022–present), she serves as a Doctoral Research Assistant, applying vibrational spectroscopy and multivariate analysis for food quality, adulteration detection, and beer evaluation 🍺📊. She also explores metabolomics for fibromyalgia diagnosis 🧠🧬. As a Teaching Assistant, she supports lab-based courses and student learning 👩‍🏫📝. In her role as Lab Safety Manager, she ensures chemical safety and compliance 🧯⚗️. At Tennessee State University (2019–2021), she developed polymer-based encapsulation, led poultry trials, and contributed to novel packaging innovations.

Awards

Ms. Haona Bao has obtained key certifications that strengthen her expertise in food safety and regulatory compliance. In July 2020, she completed Advanced HACCP and Preventive Controls Training from the Food Safety Net Services (FSNS) 🧼🧪, equipping her with in-depth knowledge of hazard analysis and critical control points. Earlier, in October 2019, she earned certification in Preventive Controls for Human Food from the Food Safety Preventive Control Alliance (FSPCA) 🥫🔍. These credentials highlight her commitment to ensuring safe food production processes and maintaining high industry standards in quality assurance and public health 🏅🌍.

Research Focus

Ms. Haona Bao specializes in Food Science and Analytical Chemistry, with a strong research focus on vibrational spectroscopy, metabolomics, and encapsulation technologies 🧪🌿. Her work bridges food quality control, functional ingredient delivery, and health diagnostics. She applies advanced spectroscopic tools like FT-IR, FT-MIR, and SERS for rapid, non-invasive diagnosis of conditions like fibromyalgia and long COVID 🧠⚡. Additionally, she explores natural polymers and essential oils in encapsulation for food and health applications 🌰🧴. Her cross-disciplinary efforts connect food safety, health monitoring, and chemical fingerprinting, making impactful contributions to nutraceuticals, rheumatology, and food authentication 📊🍷.

Publication Top Notes

Application of yellow mustard mucilage in encapsulation of essential oils and polyphenols using spray drying

Rapid biomarker-based diagnosis of fibromyalgia syndrome and related rheumatologic disorders by portable FT-IR spectroscopic techniques

Metabolic fingerprinting for the diagnosis of clinically similar long COVID and Fibromyalgia using a portable FT-MIR spectroscopic combined with chemometrics

Early diagnosis of fibromyalgia using surface-enhanced raman spectroscopy combined with chemometrics

Portable mid-infrared spectroscopy combined with chemometrics to diagnose fibromyalgia and other rheumatologic syndromes using rapid volumetric absorptive microsampling

Authentication and Quality Control of Distilled Spirits by Vibrational Spectroscopy

Heba Abdelmegeed | Medicinal Chemistry | Best Researcher Award

Published on by Top Pharmaceutical

Heba Abdelmegeed | Medicinal Chemistry | Best Researcher Award

Dr. Heba Abdelmegeed, National Research Centre, Egypt

Dr. Heba Abdelmegeed is a senior researcher at the Chemistry of Natural Compounds Department, National Research Centre, Cairo, Egypt. 🎓 She earned her Ph.D. in Immunology (Magna Cum Laude) from Technische Universität Dresden, Germany, and a Master’s in Pharmaceutical Sciences from Hokkaido University, Japan. With expertise in immunology, molecular biology, and cancer biology, she has authored impactful research on cancer therapeutics and immunomodulation. 🧪 Her diverse academic journey spans Germany, Japan, and Egypt, with multiple publications, awards, and international conference contributions. Driven by scientific curiosity, she continues to explore cutting-edge innovations in cancer biology and immunological research.

Publication Profile

Google Scholar

Education

Dr. Heba Abdelmegeed is a distinguished immunologist with a rich academic journey across three continents. She earned her Ph.D. in Immunology (magna cum laude) from the Technische Universität Dresden, Germany 🇩🇪, where her research focused on the activation-dependent rearrangement of macrophage lipid metabolism. Prior to that, she completed her M.Sc. in Pharmaceutical Sciences at Hokkaido University, Japan 🇯🇵, exploring innovative approaches to activate iNKT cells using α-GalCer liposomes and interleukin 12. Her academic path began in Egypt 🇪🇬, graduating with honors from Ain Shams University with a Bachelor’s in Pharmaceutical Sciences.

Experience

Dr. Heba Abdelmegeed is a dedicated researcher with a diverse and global professional background in pharmaceutical sciences. Since August 2020, she has served as a Senior Researcher at the Chemistry of Natural Compounds Department, NRC, Egypt 🇪🇬. Previously, she was a Ph.D. candidate at the Technical University of Dresden, Germany 🇩🇪, from 2015 to 2020. She also held the role of Assistant Researcher at NRC and was a Master’s candidate at Hokkaido University, Japan 🇯🇵. Her career began as a Quality Control Analyst at NODCAR, reflecting her strong foundation in drug analysis and research.

Research Focus

Dr. Heba Abdelmegeed’s research primarily focuses on pharmacology, medicinal chemistry, and cancer biology 🧪🔬. Her work includes developing novel anti-cancer compounds, such as quinoline and pyridine derivatives, targeting tubulin polymerization and cyclin-dependent kinases to inhibit tumor growth 🎯💊. She also explores nanoparticle drug delivery systems for enhanced antimicrobial and wound healing effects 🧫🩹. Additionally, Dr. Abdelmegeed investigates inflammation, mitochondrial function, and lipid metabolism in cancer and endocrine disorders 🔥🦠⚙️. Her multidisciplinary approach bridges molecular biology, synthetic chemistry, and computational studies to advance therapeutic strategies against cancer and infectious diseases.

Publication Top Notes

In Vivo Inverse Correlation in the Activation of Natural Killer T Cells Through Dual-Signal Stimulation via a Combination of α-Galactosylceramide–Loaded Liposomes and …

Succinate mediates inflammation-induced adrenocortical dysfunction

Coumarins: quorum sensing and biofilm formation inhibition

New heterocycles from dehydroacetic acid (DHA). Synthesis, antimicrobial activity, DNA gyrase inhibition, antioxidant activity, and molecular docking study

Chitosan nanoparticles of new chromone-based sulfonamide derivatives as effective anti-microbial matrix for wound healing acceleration

Synthetic Analogs of Marine Alkaloid Aplysinopsin Suppress Anti-Apoptotic Protein BCL2 in Prostate Cancer

Obesity-associated lipidomic remodeling of the adrenal gland indicates an important role of the FADS2-arachidonic acid axis in adrenocortical hormone production

INFLAMMATION–INDUCED DOWNREGULATION OF SUCCINATE DEHYDROGENASE REGULATES ADRENOCORTICAL FUNCTION

Exploring the antitumor potential of novel quinoline derivatives via tubulin polymerization inhibition in breast cancer; design, synthesis and molecular docking

Mitochondria in cancer: a comprehensive review, bibliometric analysis, and future perspectives

Anti colorectal cancer activity and in silico studies of novel pyridine nortopsentin analog as cyclin dependent kinase 6 inhibitor

Yan Zhang | Medicinal Chemistry | Best Researcher Award

Published on by Top Pharmaceutical

Yan Zhang | Medicinal Chemistry | Best Researcher Award  

Assoc. Prof. Dr. Yan Zhang, Hospital of Stomatology, Jilin University, China

Dr. Yan Zhang holds a Ph.D. in Stomatology from Jilin University, specializing in innovative dental implant materials, particularly magnesium-based alloys. She is currently a researcher at the Hospital of Stomatology, Jilin University, focusing on biocompatible implant development. With over 10 SCI-indexed publications, her work on the Nd-modified alloy ZNdK610 shows enhanced osteogenic potential. Dr. Zhang has completed three research projects and is actively pursuing translational research and industry collaborations. Though she has no patents or books yet, her pioneering research continues to push boundaries in implant material science.

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Yan Zhang holds a Ph.D. in Stomatology from Jilin University, with a research focus on innovative implant materials, particularly the application of magnesium alloys 🧪🦷. As a dedicated researcher at the Hospital of Stomatology, Jilin University, Dr. Zhang is actively involved in developing biocompatible materials to improve dental implant performance. Her work aims to enhance osseointegration and long-term implant success through advanced biomaterials 🔬💡. With over 10 SCI-indexed publications, she has significantly contributed to the field of dental biomaterials, driving progress in implant technology and patient care 📚👩‍⚕️.

Professional Memberships

Assoc. Prof. Dr. Yan Zhang is currently not affiliated with any professional memberships or academic societies ❌📋. Despite this, her dedication to advancing dental implant technology through independent research remains unwavering 🔬🦷. Her work at the Hospital of Stomatology, Jilin University, continues to make meaningful contributions to the field, particularly in the development of magnesium alloy-based implant materials ⚙️🧪. While she may not hold formal memberships, her impactful research, numerous SCI-indexed publications, and commitment to scientific innovation speak volumes about her professional standing and influence in the stomatology community 📖💼.

Research Focus

Assoc. Prof. Dr. Yan Zhang specializes in Periodontal Regeneration and Tissue Engineering. Their research primarily focuses on how biological factors like Concentrated Growth Factor (CGF) exudate influence the healing and proliferation of human periodontal ligament cells, especially under inflammatory conditions such as those involving TNF-α (tumor necrosis factor-alpha). This work is crucial in understanding and improving treatments for periodontal diseases by promoting tissue repair and regeneration. Dr. Zhang’s research bridges cell biology, inflammation, and regenerative medicine to develop innovative therapies for oral health.

Publication Top Notes

Concentrated growth factor exudate enhances the proliferation of human periodontal ligament cells in the presence of TNF-α

Lior Zangi | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Lior Zangi | Drug Discovery and Development | Best Researcher Award

Prof. Lior Zangi, Icahn School of Medicine at Mount Sinai, United States

Prof. Lior Zangi is an Associate Professor of Cardiology and Genetics & Genomic Sciences at the Icahn School of Medicine at Mount Sinai, NY. He earned his Ph.D. in Immunology from the Weizmann Institute and completed postdoctoral training at Harvard Medical School. Renowned for his pioneering work in mRNA-based cardiovascular therapies, Prof. Zangi has received prestigious awards including the AHA Postdoctoral Fellowship and an endowed professorship in Cardiovascular Research. He is a founding board member of the Society for RNA Therapeutics and actively contributes to global scientific councils, manuscript reviews, and grant panels.

Publication Profile

Google Scholar

Education

Prof. Lior Zangi 🎓 began his academic journey with a B.Sc. in Biology from the Hebrew University, Givat-Ram, Jerusalem in 2000. He then earned his M.Sc. in Experimental and Developmental Medicine in 2003 from the Hebrew University Hadassah-Medical School under the guidance of Prof. Raphael Gorodetsky. In 2009, he completed his Ph.D. in Immunology at the Weizmann Institute of Science, mentored by Prof. Yair Reisner. 🌿 He continued his training as a postdoctoral fellow at Sheba Medical Center (2009–2010) under Prof. Benjamin Dekel and later at Harvard Medical School (2010–2014) with Professors Derrick Rossi and Kenneth Chien.

Awards

Prof. Lior Zangi 🌟 has earned numerous prestigious honors throughout his career. He received the ASH Travel Award in both 2008 and 2009 🧳, and in 2009, was granted a Postdoctoral Fellowship Award by the Israeli Budgeting Committee and Planning. In 2012, he was honored with both the ISSCR Travel Award and R&D Systems Travel Grant ✈️. His groundbreaking postdoctoral work earned him the AHA Fellowship Award in 2014 🫀. In 2017, he received the Mount Sinai Faculty Idea Prize 🧠, and in 2019, his research on mRNA therapy was recognized as highly influential 📜. In 2023, he was awarded the Endowed Chan Soon-Shiong Professorship in Cardiovascular Research 🏅.

Research Focus

Prof. Lior Zangi is a pioneering researcher in cardiovascular regenerative medicine, with a special focus on modified mRNA therapies, 🧬 stem cell biology, and 🫀 cardiac regeneration. His work centers on developing innovative strategies for repairing damaged heart tissue using modRNA, induced pluripotent stem cells (iPSCs), and heart-on-chip technologies. Zangi’s groundbreaking research has contributed to advancements in treating conditions like myocardial infarction and Barth syndrome, and has broad implications for tissue engineering, 💉 protein replacement therapy, and immune modulation. His contributions are reshaping modern precision medicine and offering new hope for heart failure patients worldwide.

Publication Top Notes

Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction

Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads

Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells

A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells

Isolation and characterization of nontubular sca-1+ lin− multipotent stem/progenitor cells from adult mouse kidney

Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration

mRNA-based protein replacement therapy for the heart

Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction

TRAN CHAUMYTHANH | Medicinal Chemistry | Young Scientist Award

Published on by Top Pharmaceutical

TRAN CHAUMYTHANH | Medicinal Chemistry | Young Scientist Award

Dr. TRAN CHAUMYTHANH, DUYTAN UNIVERSITY, Vietnam

Dr. Chaumy Thanh Tran is a dedicated medical doctor and Ph.D. holder from Hue University of Medicine and Pharmacy, Vietnam. Her groundbreaking research integrates online medical databases and sequencing technologies to explore biomarkers for early disease detection—including diabetes, cardiovascular diseases, stroke, and cancers. She focuses on gene-targeted drug development and CRISPR/Cas9 gene editing. From 2023 to 2025, her work on LncRNA/CircRNA/miRNA/gene/protein-drug networks stands out as a vital resource for molecular biology. With several publications in high-impact journals (SCI, Scopus), Dr. Tran’s innovations aim to elevate human health and therapeutic strategies worldwide.

Publication Profile

Scopus

Education

Dr. Tran Chaumythanh 🎓 is a dedicated medical professional with a strong academic foundation in medicine. She earned her Medical Doctor (MD) degree from Hue University of Medicine and Pharmacy, Vietnam 🏥, where she also pursued and completed her Doctorate (Ph.D.) in the same esteemed institution 📚. With a commitment to advancing healthcare and medical education, Dr. Chaumythanh combines clinical expertise with academic excellence, contributing to both patient care and research innovation. Her journey reflects a passion for medicine and a continuous drive for knowledge, shaping her as a respected figure in Vietnam’s medical and academic communities 🌟.

Research Experience

Dr. Tran Chaumythanh 🔬 is at the forefront of cutting-edge research in molecular biology, leveraging online medical databases and next-generation sequencing technologies to advance modern disease studies. Her work focuses on identifying early biomarkers 🧬 for diabetes, cardiovascular diseases, strokes, and cancers. She also explores gene targets for novel drug development 💊 and utilizes gene-editing tools like CRISPR/Cas9 to correct harmful mutations 🧪. From 2023 to 2025, her investigations delve into the complex interaction networks of LncRNA, CircRNA, miRNA, genes, and proteins, aiming to build a comprehensive knowledge base for future therapeutic innovations and precision medicine 🔗📈.

Research Focus

Dr. Tran ChaumyThanh’s research primarily centers on bioinformatics-driven analysis of latent tuberculosis (TB), with a strong focus on gene and miRNA regulatory networks, immune cell infiltration, and potential drug-gene interactions. Utilizing microarray data analysis, molecular docking, and molecular dynamics simulation, her work aims to identify novel therapeutic targets and unravel complex host-pathogen interactions. This multidisciplinary approach bridges computational biology, immunology, and pharmacology, contributing to precision medicine and effective TB management. 🧪📊🧠 Her research holds promise for developing targeted therapies and improving our understanding of latent TB immune mechanisms.

Publication Top Notes

Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation

Prof. Cedrick MUTOMBO SHAKALENGA |Medicinal Chemistry| Best Researcher Award

Published on by Top Pharmaceutical

Prof. Cedrick MUTOMBO SHAKALENGA,Medicinal Chemistry,Best Researcher Award

Prof. Cedrick MUTOMBO SHAKALENGA, at University of Lubumbashi,Democratic Republic Congo

PROFILE

Orcid

Scopus

Google scholar

📚Early Academic Pursuits :

Cedrick Mutombo Shakalenga was born on February 26, 1991, in Manono, a town located in the Democratic Republic of Congo. His academic journey began in Mukushi / Manono Primary School, where he obtained his Primary School Certificate in 2003. Cedrick then pursued secondary education at the Bunyinge / Manono Institute, earning a State Diploma in General Pedagogy in 2009. His passion for pharmaceutical sciences led him to enroll at the University of Lubumbashi, where he completed a Pharmacist Diploma with a specialization in Hospital & Community Pharmacy in 2016.

🏢Professional Endeavors :

Cedrick’s professional career is marked by significant milestones and diverse roles within the pharmaceutical field. His early work experience includes teaching at Maendeleo/Lusa Primary School in Manono from 2009 to 2010 and serving as a Pharmacist at the Tamtam Pharmacy in Lubumbashi during 2014-2015. His academic career took off when he joined the University of Lubumbashi’s Faculty of Pharmaceutical Sciences as a Teaching Assistant from 2018 to 2022.

In 2023, Cedrick was promoted to Associate Professor at the same institution, where he now lectures on Biophysics I and II and Traditional Medicine. Additionally, he has contributed significantly to the scientific community through his role as a Scientific Research Officer at the “Jardin d’Etude Pharmaceutiques” club.

🔬Contributions and Research Focus :

Cedrick’s research is centered on integrating traditional medicine into the official health system of DR Congo. His Ph.D. thesis, titled “Conditions for the Integration of Traditional Medicine into the Official Health System in DR Congo, Case of Lubumbashi city,” reflects his dedication to this cause. He has co-authored several influential publications that explore various aspects of traditional medicine, pharmacognosy, and public health. His research not only highlights the socio-economic importance of medicinal plants but also addresses public health challenges in DR Congo.

 

🏅Accolades and Recognition :

Cedrick’s dedication and contributions to the field of pharmaceutical sciences have been widely recognized. In 2023, he received the prestigious “Peter Hylands award” for his poster presentation at the 11th Annual Meeting of The Good Practice in Traditional Chinese Medicine Research Association (GP-TCM RA). His research on the authentication of Securidaca longepedunculata Fresen., a highly sought-after medicinal plant, earned him this accolade.

🌍Impact and Influence :

Cedrick’s work has had a profound impact on the field of traditional medicine in DR Congo. His efforts to integrate traditional practices into the formal health system have the potential to improve healthcare accessibility and affordability for many Congolese citizens. By advocating for the scientific validation and quality control of traditional medicines, Cedrick is helping to bridge the gap between traditional and modern medical practices.

🚀Legacy and Future Contributions :

Cedrick Mutombo Shakalenga’s legacy lies in his unwavering commitment to enhancing the pharmaceutical landscape in DR Congo. His pioneering research and advocacy for traditional medicine integration have set a foundation for future advancements in the field. As an Associate Professor, he continues to inspire and mentor the next generation of pharmaceutical scientists, ensuring that his impact will resonate for years to come.

📝Conclusion :

Cedrick Mutombo Shakalenga’s journey from a small town in Manono to becoming an influential figure in pharmaceutical sciences is a testament to his dedication, hard work, and visionary approach. His contributions to traditional medicine, his extensive research portfolio, and his role as an educator highlight his multifaceted impact on the scientific community and society at large. Cedrick’s ongoing efforts and future endeavors promise to further advance the integration of traditional and modern medicine, ultimately improving healthcare outcomes in DR Congo and beyond.

🎓Publication 

Quality control of herbal drugs and preparations: The methods of analysis, their relevance and applications

  • Authors   :N.W Muyumba, S.C Mutombo, H Sheridan, A Nachtergael, Duez P
  • Journal    :Talanta Open
  • Year         : 2021

Perceptions and use of traditional African medicine in Lubumbashi, Haut-Katanga province (DR Congo): A cross-sectional study

    • Authors :SC Mutombo, AS Bakari, NV Ntabaza, A Nachtergael, SJB Lumbu, P Duez, BJ Kahumba
    • Journal   :PLoS ONE
    • Year       : 2022

Knowledge, attitudes and practices among the population, towards COVID-19 in the Lubumbashi city (DR Congo): An online cross-sectional survey

  • Authors  :MH Manya, SC Mutombo, CV Bashige, Nzuzi MG, TA Kabamba, MA Mutombo, MC Kibwe, MO Moke, JC Nkwanga, NT Nsumbu, AS Bakari, BJ Kahumba, SJB Lumbu
  • Journal    :World Journal of Biology Pharmacy and Health Sciences
  • Year         :  2021

Knowledge, attitude, and practice towards hepatitis B and C viruses among the population of Lubumbashi, Democratic Republic of Congo

  • Authors  :TA Kabamba, MH Manya, SC Mutombo, BC Kasongo, CKC Kakisingi, KS Matanda, MA Mutombo, MC Mwamba, NA Ngulu, MB Kabamba, OA Longanga
  • Journal   :African Journal of Gastroenterology and Hepatology
  • Year        :   2023

 

Mineral elements analysis and total flavonoids content in the fresh leaves from two varieties of Hibiscus sabdariffa L. consumed as vegetable in Lubumbashi (DR Congo)

  • Authors  :Shakalenga Cedrick Mutombo, Mboni Henry Manya, Nkulu Salvator Nsenga, Mavungu Gaël Nzuzi, Mwenya Cynthia Kibwe, Mwinensenge James Maloba, Chiribagula Valentin Bashige, Amuri Salvius Bakari, Byanga Joh Kahumba, Badibanga Bualufu Victor Ndibualonji
  • Journal   :World Journal of Advanced Research and Reviews
  • Year        :   2021